Skip to main content

Peer Review reports

From: FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomide

Original Submission
30 Jun 2021 Submitted Original manuscript
26 Jul 2021 Reviewed Reviewer Report
27 Jul 2021 Reviewed Reviewer Report - Khabab Abbasher Hussien Mohamed Ahmed
18 Aug 2021 Reviewed Reviewer Report
10 Sep 2021 Author responded Author comments - Kaijia Zhou
Resubmission - Version 2
10 Sep 2021 Submitted Manuscript version 2
6 Oct 2021 Reviewed Reviewer Report
11 Oct 2021 Reviewed Reviewer Report
28 Oct 2021 Author responded Author comments - Kaijia Zhou
Resubmission - Version 3
28 Oct 2021 Submitted Manuscript version 3
Publishing
29 Oct 2021 Editorially accepted
9 Nov 2021 Article published 10.1186/s12883-021-02476-2

You can find further information about peer review here.

Back to article page